Calmark Sweden AB (publ)

NGM:CALMA B Stock Report

Market Cap: SEK 11.0m

Calmark Sweden Past Earnings Performance

Past criteria checks 0/6

Calmark Sweden's earnings have been declining at an average annual rate of -39.3%, while the Medical Equipment industry saw earnings growing at 5.9% annually. Revenues have been declining at an average rate of 31.7% per year.

Key information

-39.3%

Earnings growth rate

-17.9%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate-31.7%
Return on equity-54.1%
Net Margin-16,348.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Calmark Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NGM:CALMA B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-22170
30 Sep 230-32200
30 Jun 230-44220
31 Mar 230-47240
31 Dec 220-48250
30 Sep 221-41250
30 Jun 223-29250
31 Mar 226-27270
31 Dec 219-22280
30 Sep 2110-18280
30 Jun 2111-15250
31 Mar 219-12210
31 Dec 2010-11200
30 Sep 2017-9260
30 Jun 2015-9240
31 Mar 2012-9210
31 Dec 1911-8190
30 Sep 196-7130
30 Jun 195-7120
31 Mar 197-6130
31 Dec 185-5100
30 Sep 183-470
30 Jun 183-460
31 Mar 182-350
31 Dec 172-350
31 Dec 160-220

Quality Earnings: CALMA B is currently unprofitable.

Growing Profit Margin: CALMA B is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CALMA B is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.

Accelerating Growth: Unable to compare CALMA B's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CALMA B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (27.6%).

Return on Equity

High ROE: CALMA B has a negative Return on Equity (-54.09%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/08 10:57
End of Day Share Price 2024/03/08 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Calmark Sweden AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oscar BergmanRedeye